Type 2 Diabetes Trial, Recruiting NCT07173543 Sponsor: Darren P Casey Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07173543
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has two groups: people with Type 2 diabetes, and people without diabetes (control group). The criteria for each group are listed separately below.

Group 1 – People with Type 2 diabetes:

Who might be able to join this trial:

  • People who are willing and able to sign a written consent form after the study has been fully explained to them, before any study procedures begin
  • People between the ages of 60 and 85 (inclusive)
  • People with a documented Type 2 diabetes diagnosis
  • People who score 26 or higher on a memory and thinking test called the MoCA

Who may not be able to join:

  • People whose Type 2 diabetes was diagnosed less than 1 year before enrolling in the trial
  • People whose long-term blood sugar level (HbA1c) falls below 6.5% or above 10.0%
  • People with a body mass index (a measure of body weight relative to height) over 40
  • People who have had a heart attack or stroke in the past year
  • People with active chest pain or symptoms related to heart disease, or heart failure
  • People with uncontrolled high blood pressure
  • People diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep)
  • People with a lung or breathing disease
  • People diagnosed with dementia
  • People whose kidneys are not filtering blood well enough (confirmed by a specific kidney function measurement)
  • People who currently smoke or have smoked within the past year

Group 2 – People without diabetes (control group):

Who might be able to join this trial:

  • People who are willing and able to sign a written consent form after the study has been fully explained to them, before any study procedures begin
  • People between the ages of 60 and 85 (inclusive)
  • People who score 26 or higher on a memory and thinking test called the MoCA

Who may not be able to join:

  • People who have been diagnosed with any type of diabetes (Type 1 or Type 2)
  • People with a body mass index (a measure of body weight relative to height) over 40
  • People who have had a heart attack or stroke in the past year
  • People with active chest pain or symptoms related to heart disease, or heart failure
  • People with uncontrolled high blood pressure
  • People diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep)
  • People with a lung or breathing disease
  • People diagnosed with dementia
  • People whose kidneys are not filtering blood well enough (confirmed by a specific kidney function measurement)
  • People who currently smoke or have smoked within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13193841009

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Darren P Casey
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Internal Carotid Artery (ICA) shear-mediated dilation; Cerebral blood flow responsiveness; Cognitive function testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov